Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study findings suggest this circuitry might be targeted in potential therapies for a variety of substance use disorders.
People of color with depression are more likely to be underdiagnosed and untreated.
Findings show that psychedelic psilocybin-containing mushrooms could effectively reduce symptoms of anxiety and depression.
Proponents hope that decriminalizing pot will help address widespread and longstanding issues of racial inequity.
A news study finds that only 8% of mass shooters suffer from serious mental illness.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
Nearly a third of teens and young adults improperly use tranquilizers, stimulants and other psychoactive drugs.
Chronic pain is common among people with HIV, but it may not drive opioid use disorder.
Men in jail who have posttraumatic stress disorder, panic disorder and alcohol use disorder are more likely to commit violent crimes.
Depression and anxiety have worsened since the pandemic, which has led to more people using drugs and alcohol.
The greatest increase in such visits was among girls ages 15 to 17, mostly related to substance use and self-harm.
Regardless of age or gender, people with mood disorders experience higher rates of premature mortality.
A recent opinion piece in the Columbia Journalism Review argues that the distinction matters.
The 2018 annual survey also shows prescription drug abuse is expanding and opioid-related deaths are on the rise.
The risk is particularly high the first year after receiving an HIV diagnosis.
People with chronic conditions or who need expensive meds could be more vulnerable. Here’s why.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.